The problem of pertussis in some regions of the world

Pertussis infection remains a high-priority issue both for Russian health care and abroad. A rise of pertussis incidence in various human age groups instigates a search for new ways to fight this infection and improve methods for its laboratory diagnostics. By taking into consideration a short-term...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A. A Basov, O. V Tsvirkun, A. G Gerasimova, A. K Zekoreeva
Formato: article
Lenguaje:RU
Publicado: Sankt-Peterburg : NIIÈM imeni Pastera 2019
Materias:
Acceso en línea:https://doaj.org/article/31ea9f3dae9f43868946509c1305f718
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:31ea9f3dae9f43868946509c1305f718
record_format dspace
spelling oai:doaj.org-article:31ea9f3dae9f43868946509c1305f7182021-11-22T07:09:53ZThe problem of pertussis in some regions of the world2220-76192313-739810.15789/2220-7619-2019-2-354-362https://doaj.org/article/31ea9f3dae9f43868946509c1305f7182019-07-01T00:00:00Zhttps://www.iimmun.ru/iimm/article/view/713https://doaj.org/toc/2220-7619https://doaj.org/toc/2313-7398Pertussis infection remains a high-priority issue both for Russian health care and abroad. A rise of pertussis incidence in various human age groups instigates a search for new ways to fight this infection and improve methods for its laboratory diagnostics. By taking into consideration a short-term effect induced by acellular and whole-cell vaccines, a feasibility of introducing the second or even the third pertussis revaccination is vigorously debated. Objective of the study was to analyze the experience and effectiveness of acellular pertussis vaccines in countries, which use the second and third pertussis revaccination in the National Immunization Schedule in order to have an insight into adjusting strategy and tactics of pertussis immunization In Russia. Analyzing pertussis prevalence demonstrated that despite a wide immunization coverage pertussis incidence in the last years (2008–2015) was increased in a large number of countries in the European region, as well as inAustralia,CanadaandUSA. However, the reasons for elevated pertussis incidence have not been clarified yet. On one hand, it may be accounted for by low vaccination coverage in adolescents and adults; weakened immune protection after vaccination; genetic changes in Bordetella pertussis; shortened durability of protective immunity in children vaccinated with acellular vs. whole-cell vaccine; improved monitoring and morbidity reporting, as well as improved laboratory diagnostics due to shifting from serological and bacteriological to molecular genetic assays. In an attempt to solve this issue, researchers from several countries collaborate to discuss and develop a strategy to reduce pertussis incidence. ForRussia, the most important is to empower and/or improve existing infant immunization strategy in order to provide wide coverage with the four dose pertussis vaccine for decreasing the risk of pertussis morbidity and mortality. It is worth noting the “cocoon” strategy given the high risk of pertussis infection in children of the first months of life. We believe that forRussiait is worth investigating an opportunity of using children 2–3 months of life an acellular vaccine as the first vaccination, which is expected to increase the coverage of this cohort and allow to increase proportion of children who might complete vaccination by 5 months of age. At the same time, more reasonable might be to preserve a number of age groups for pertussis vaccination in the current National Immunization Schedule, as expanding age limits for vaccination might put a risk at increasing pertussis morbidity in older individuals, which could be hard to diagnose.A. A BasovO. V TsvirkunA. G GerasimovaA. K ZekoreevaSankt-Peterburg : NIIÈM imeni Pasteraarticlepertussisacellular vaccinesvaccinesimmunizationrevaccinationimmunization scheduleincidenceInfectious and parasitic diseasesRC109-216RUInfekciâ i Immunitet, Vol 9, Iss 2, Pp 354-362 (2019)
institution DOAJ
collection DOAJ
language RU
topic pertussis
acellular vaccines
vaccines
immunization
revaccination
immunization schedule
incidence
Infectious and parasitic diseases
RC109-216
spellingShingle pertussis
acellular vaccines
vaccines
immunization
revaccination
immunization schedule
incidence
Infectious and parasitic diseases
RC109-216
A. A Basov
O. V Tsvirkun
A. G Gerasimova
A. K Zekoreeva
The problem of pertussis in some regions of the world
description Pertussis infection remains a high-priority issue both for Russian health care and abroad. A rise of pertussis incidence in various human age groups instigates a search for new ways to fight this infection and improve methods for its laboratory diagnostics. By taking into consideration a short-term effect induced by acellular and whole-cell vaccines, a feasibility of introducing the second or even the third pertussis revaccination is vigorously debated. Objective of the study was to analyze the experience and effectiveness of acellular pertussis vaccines in countries, which use the second and third pertussis revaccination in the National Immunization Schedule in order to have an insight into adjusting strategy and tactics of pertussis immunization In Russia. Analyzing pertussis prevalence demonstrated that despite a wide immunization coverage pertussis incidence in the last years (2008–2015) was increased in a large number of countries in the European region, as well as inAustralia,CanadaandUSA. However, the reasons for elevated pertussis incidence have not been clarified yet. On one hand, it may be accounted for by low vaccination coverage in adolescents and adults; weakened immune protection after vaccination; genetic changes in Bordetella pertussis; shortened durability of protective immunity in children vaccinated with acellular vs. whole-cell vaccine; improved monitoring and morbidity reporting, as well as improved laboratory diagnostics due to shifting from serological and bacteriological to molecular genetic assays. In an attempt to solve this issue, researchers from several countries collaborate to discuss and develop a strategy to reduce pertussis incidence. ForRussia, the most important is to empower and/or improve existing infant immunization strategy in order to provide wide coverage with the four dose pertussis vaccine for decreasing the risk of pertussis morbidity and mortality. It is worth noting the “cocoon” strategy given the high risk of pertussis infection in children of the first months of life. We believe that forRussiait is worth investigating an opportunity of using children 2–3 months of life an acellular vaccine as the first vaccination, which is expected to increase the coverage of this cohort and allow to increase proportion of children who might complete vaccination by 5 months of age. At the same time, more reasonable might be to preserve a number of age groups for pertussis vaccination in the current National Immunization Schedule, as expanding age limits for vaccination might put a risk at increasing pertussis morbidity in older individuals, which could be hard to diagnose.
format article
author A. A Basov
O. V Tsvirkun
A. G Gerasimova
A. K Zekoreeva
author_facet A. A Basov
O. V Tsvirkun
A. G Gerasimova
A. K Zekoreeva
author_sort A. A Basov
title The problem of pertussis in some regions of the world
title_short The problem of pertussis in some regions of the world
title_full The problem of pertussis in some regions of the world
title_fullStr The problem of pertussis in some regions of the world
title_full_unstemmed The problem of pertussis in some regions of the world
title_sort problem of pertussis in some regions of the world
publisher Sankt-Peterburg : NIIÈM imeni Pastera
publishDate 2019
url https://doaj.org/article/31ea9f3dae9f43868946509c1305f718
work_keys_str_mv AT aabasov theproblemofpertussisinsomeregionsoftheworld
AT ovtsvirkun theproblemofpertussisinsomeregionsoftheworld
AT aggerasimova theproblemofpertussisinsomeregionsoftheworld
AT akzekoreeva theproblemofpertussisinsomeregionsoftheworld
AT aabasov problemofpertussisinsomeregionsoftheworld
AT ovtsvirkun problemofpertussisinsomeregionsoftheworld
AT aggerasimova problemofpertussisinsomeregionsoftheworld
AT akzekoreeva problemofpertussisinsomeregionsoftheworld
_version_ 1718417908443381760